Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Novartis
Queensland Health
Boehringer Ingelheim
US Department of Justice
Cipla
AstraZeneca
McKesson
Farmers Insurance
Julphar

Generated: February 19, 2018

DrugPatentWatch Database Preview

Ceftazidime - Generic Drug Details

« Back to Dashboard

What are the generic sources for ceftazidime and what is the scope of ceftazidime patent protection?

Ceftazidime
is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Teligent, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Five suppliers are listed for this compound.
Pharmacology for ceftazidime
Medical Subject Heading (MeSH) Categories for ceftazidime

US Patents and Regulatory Information for ceftazidime

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-001 Apr 28, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline PENTACEF ceftazidime INJECTABLE;INJECTION 064008-002 Mar 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065481-001 May 28, 2010 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly TAZIDIME IN PLASTIC CONTAINER ceftazidime INJECTABLE;INJECTION 062739-002 Jul 10, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-001 Jul 19, 1985 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065196-001 Oct 15, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira TAZICEF ceftazidime INJECTABLE;INJECTION 062662-004 Mar 6, 1986 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline PENTACEF ceftazidime INJECTABLE;INJECTION 064006-001 Mar 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline CEPTAZ ceftazidime INJECTABLE;INJECTION 050646-002 Sep 27, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-004 Feb 3, 1992 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Moodys
Chubb
Medtronic
AstraZeneca
UBS
McKinsey
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot